Patent ID: 9068197
Filing Date: 2015-06-30
Classification: C12N

Abstract:
1. An multicistronic expression vector suitable for use in a mammalian host cell comprising the following polynucleotide sequences: a) an isolated first polynucleotide sequence comprising from 5′ to 3′ direction: (i) four copies of the GAL4 upstream activating sequence (UAS) comprising nucleotides 19-35, 38-54, 57-73, and 76-92 of SEQ ID NO: 1 and two or more first transcriptional elements comprising a TATA box promoter element comprising nucleotides 148-153 of SEQ ID NO:1, (ii) one or more first translational enhancer elements (TEE) comprising one N18 random oligonucleotide sequence comprising nucleotides 190-207 of SEQ ID NO: 1, and (iii) a first cistron comprising nucleotides 214-897 of SEQ ID NO:1 and encoding a transcription factor, wherein the transcription factor is yeast regulatory protein GAL4/viral protein 16 (GAL4/VP 16), and wherein said N18 is operably linked to the first cistron and increases the amount of GAL4/viral protein induced per unit mRNA; and b) an isolated second polynucleotide sequence comprising from 5′ to 3′ direction: (i) at least one second transcriptional element comprising a TATA box promoter element comprising nucleotides 1347-1352 of SEQ ID NO:1 and four copies of the GAL/UAS comprising nucleotides 1224-1240, 1243-1259, 1262-1278 and 1281-1297 of SEQ ID NO: 1, (ii) at least one second TEE comprising internal ribosome entry sites (IRES) elements, and (iii) a second cistron encoding a second gene product, wherein said TEE is operably linked to the second cistron, wherein said first and second polynucleotide sequences are functionally linked, wherein upon expression of the GAL4/VP16 in the mammalian host cell, GAL4/VP16 binds to GAL4 UAS sites in the transcriptional element promoters of the first and second polynucleotide sequences, thereby amplifying the transcription of at least the first cistron of the first polynucleotide sequence and the second cistron of the second polynucleotide sequence.